The FDA offers various resources to assist stakeholders in the nanotechnology field, including:
Guidance documents that outline regulatory expectations. Workshops and public meetings to facilitate dialogue between the FDA and industry. Collaborative research initiatives to advance the understanding of nanotechnology.
